SAENGER BRADLEY 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed May 6, 2020
Insider Transaction Report
Form 4
SAENGER BRADLEY
Chief Financial Officer
Transactions
- Award
Stock Option
2020-05-04+360,000→ 360,000 totalExercise: $0.77From: 2021-05-04Exp: 2030-05-04→ Common Stock (360,000 underlying) - Award
Stock Option
2020-05-04+360,000→ 360,000 totalExercise: $0.96From: 2021-05-04Exp: 2030-05-04→ Common Stock (360,000 underlying)
Footnotes (2)
- [F1]The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.